Erik Hahn, MS, is currently a Clinical Pharmacology Lead at Pfizer in Global Product Development - Clin Pharm Oncology. He earned his Master of Science in Pharmacometrics from the University of Maryland School of Pharmacy. He currently works on the development of small molecules and pharmacometric analyses. He has been a member of ASCPT since 2018.